Clearly, CD8+ T cells are major effector cells in anti-viral and anti-tumoral immunity in cHCV infection and HCC and CD8+ T cell impairment is common in both liver-associated diseases. The gene discussed is CD8A; the disease is hepatocellular carcinoma.